Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 4(12), 2022
DOI: 10.1038/s41408-022-00667-9
Links
Tools
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
Journal article published in 2022 by
Shady Adnan Awad 
,
Oscar Brück ,
Naranie Shanmuganathan ,
Timo Jarvinen,
Hanna Lähteenmäki,
Jay Klievink,
Hazem Ibrahim ,
Soili Kytölä,
Perttu Koskenvesa,
Timothy P. Hughes ,
Susan Branford ,
Matti Kankainen ,
Satu Mustjoki
,
Oscar Brück ,
Naranie Shanmuganathan ,
Timo Jarvinen,
Hanna Lähteenmäki,
Jay Klievink,
Hazem Ibrahim ,
Soili Kytölä,
Perttu Koskenvesa,
Timothy P. Hughes ,
Susan Branford ,
Matti Kankainen ,
Satu Mustjoki
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 